Go offline with the Player FM app!
Therapy In Limbo: The FDA's MDMA Decision & What Went Wrong
Manage episode 424437882 series 2813395
Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results.
The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.
Follow Kennedy on Twitter: @KennedyNation
Kennedy Now Available on YouTube: https://bit.ly/4311mhD.
Learn more about your ad choices. Visit megaphone.fm/adchoices
403 episodes
Manage episode 424437882 series 2813395
Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results.
The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.
Follow Kennedy on Twitter: @KennedyNation
Kennedy Now Available on YouTube: https://bit.ly/4311mhD.
Learn more about your ad choices. Visit megaphone.fm/adchoices
403 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.